EMEA (Europe, Middle East and Africa) Neuroprotection Market Report 2018

March 2018 | 100 pages | ID: E8BA06A5498EN
QYResearch

Abstracts

In this report, the EMEA Neuroprotection market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Neuroprotection for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Neuroprotection market competition by top manufacturers/players, with Neuroprotection sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Daiichi Sankyo Company
• Eli Lilly and Company
• Allergan
• Dr. Reddy’s Laboratories
• Teva Pharmaceutical
• Novartis
• AstraZeneca
• Astrocyte Pharmaceuticals
• F. Hoffmann-La Roche
• Biogen

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Free Radical Trapping Agents (Antioxidants)
• Glutamate Antagonists (Anti-Excitotoxic Agents)
• Apoptosis Inhibitors
• Anti-inflammatory Agents
• Neurotrophic Factors (NTFs)
• Metal Ion Chelators
• Stimulants
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Prevention
• Treatment

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Neuroprotection Market Report 2018

1 NEUROPROTECTION OVERVIEW

1.1 Product Overview and Scope of Neuroprotection
1.2 Classification of Neuroprotection
  1.2.1 EMEA Neuroprotection Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Neuroprotection Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Free Radical Trapping Agents (Antioxidants)
  1.2.4 Glutamate Antagonists (Anti-Excitotoxic Agents)
  1.2.5 Apoptosis Inhibitors
  1.2.6 Anti-inflammatory Agents
  1.2.7 Neurotrophic Factors (NTFs)
  1.2.8 Metal Ion Chelators
  1.2.9 Stimulants
  1.2.10 Others
1.3 EMEA Neuroprotection Market by Application/End Users
  1.3.1 EMEA Neuroprotection Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Prevention
  1.3.3 Treatment
1.4 EMEA Neuroprotection Market by Region
  1.4.1 EMEA Neuroprotection Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Neuroprotection (2013-2025)
  1.5.1 EMEA Neuroprotection Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Neuroprotection Revenue and Growth Rate (2013-2025)

2 EMEA NEUROPROTECTION COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Neuroprotection Market Competition by Players/Manufacturers
  2.1.1 EMEA Neuroprotection Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Neuroprotection Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Neuroprotection Sale Price by Players (2013-2018)
2.2 EMEA Neuroprotection (Volume and Value) by Type/Product Category
  2.2.1 EMEA Neuroprotection Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Neuroprotection Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Neuroprotection Sale Price by Type (2013-2018)
2.3 EMEA Neuroprotection (Volume) by Application
2.4 EMEA Neuroprotection (Volume and Value) by Region
  2.4.1 EMEA Neuroprotection Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Neuroprotection Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Neuroprotection Sales Price by Region (2013-2018)

3 EUROPE NEUROPROTECTION (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Neuroprotection Sales and Value (2013-2018)
  3.1.1 Europe Neuroprotection Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Neuroprotection Revenue and Growth Rate (2013-2018)
3.2 Europe Neuroprotection Sales and Market Share by Type
3.3 Europe Neuroprotection Sales and Market Share by Application
3.4 Europe Neuroprotection Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Neuroprotection Sales Volume by Countries (2013-2018)
  3.4.2 Europe Neuroprotection Revenue by Countries (2013-2018)
  3.4.3 Germany Neuroprotection Sales and Growth Rate (2013-2018)
  3.4.4 France Neuroprotection Sales and Growth Rate (2013-2018)
  3.4.5 UK Neuroprotection Sales and Growth Rate (2013-2018)
  3.4.6 Russia Neuroprotection Sales and Growth Rate (2013-2018)
  3.4.7 Italy Neuroprotection Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Neuroprotection Sales and Growth Rate (2013-2018)

4 MIDDLE EAST NEUROPROTECTION (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Neuroprotection Sales and Value (2013-2018)
  4.1.1 Middle East Neuroprotection Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Neuroprotection Revenue and Growth Rate (2013-2018)
4.2 Middle East Neuroprotection Sales and Market Share by Type
4.3 Middle East Neuroprotection Sales and Market Share by Application
4.4 Middle East Neuroprotection Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Neuroprotection Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Neuroprotection Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Neuroprotection Sales and Growth Rate (2013-2018)
  4.4.4 Israel Neuroprotection Sales and Growth Rate (2013-2018)
  4.4.5 UAE Neuroprotection Sales and Growth Rate (2013-2018)
  4.4.6 Iran Neuroprotection Sales and Growth Rate (2013-2018)

5 AFRICA NEUROPROTECTION (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Neuroprotection Sales and Value (2013-2018)
  5.1.1 Africa Neuroprotection Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Neuroprotection Revenue and Growth Rate (2013-2018)
5.2 Africa Neuroprotection Sales and Market Share by Type
5.3 Africa Neuroprotection Sales and Market Share by Application
5.4 Africa Neuroprotection Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Neuroprotection Sales Volume by Countries (2013-2018)
  5.4.2 Africa Neuroprotection Revenue by Countries (2013-2018)
  5.4.3 South Africa Neuroprotection Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Neuroprotection Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Neuroprotection Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Neuroprotection Sales and Growth Rate (2013-2018)

6 EMEA NEUROPROTECTION MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Daiichi Sankyo Company
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Neuroprotection Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Daiichi Sankyo Company Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Eli Lilly and Company
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Neuroprotection Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Eli Lilly and Company Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Allergan
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Neuroprotection Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Allergan Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Dr. Reddy’s Laboratories
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Neuroprotection Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Dr. Reddy’s Laboratories Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Teva Pharmaceutical
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Neuroprotection Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Teva Pharmaceutical Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Novartis
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Neuroprotection Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Novartis Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 AstraZeneca
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Neuroprotection Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 AstraZeneca Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Astrocyte Pharmaceuticals
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Neuroprotection Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Astrocyte Pharmaceuticals Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 F. Hoffmann-La Roche
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Neuroprotection Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 F. Hoffmann-La Roche Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Biogen
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Neuroprotection Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Biogen Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview

7 NEUROPROTECTION MANUFACTURING COST ANALYSIS

7.1 Neuroprotection Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Neuroprotection

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Neuroprotection Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Neuroprotection Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA NEUROPROTECTION MARKET FORECAST (2018-2025)

11.1 EMEA Neuroprotection Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Neuroprotection Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Neuroprotection Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Neuroprotection Price and Trend Forecast (2018-2025)
11.2 EMEA Neuroprotection Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Neuroprotection Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Neuroprotection Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Neuroprotection Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Neuroprotection Sales Forecast by Type (2018-2025)
11.7 EMEA Neuroprotection Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Neuroprotection
Figure EMEA Neuroprotection Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Neuroprotection Sales Volume Market Share by Type (Product Category) in 2017
Figure Free Radical Trapping Agents (Antioxidants) Product Picture
Figure Glutamate Antagonists (Anti-Excitotoxic Agents) Product Picture
Figure Apoptosis Inhibitors Product Picture
Figure Anti-inflammatory Agents Product Picture
Figure Neurotrophic Factors (NTFs) Product Picture
Figure Metal Ion Chelators Product Picture
Figure Stimulants Product Picture
Figure Others Product Picture
Figure EMEA Neuroprotection Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Neuroprotection by Application in 2017
Figure Prevention Examples
Table Key Downstream Customer in Prevention
Figure Treatment Examples
Table Key Downstream Customer in Treatment
Figure EMEA Neuroprotection Market Size (Million USD) by Region (2013-2025)
Figure Europe Neuroprotection Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Neuroprotection Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Neuroprotection Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Neuroprotection Revenue (Million USD) Status and Forecast by Countries
Figure Africa Neuroprotection Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Neuroprotection Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Neuroprotection Sales Volume and Growth Rate (2013-2025)
Figure EMEA Neuroprotection Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Neuroprotection Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Neuroprotection Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Neuroprotection Sales Share by Players (2013-2018)
Figure 2017 Neuroprotection Sales Share by Players
Figure 2017 Neuroprotection Sales Share by Players
Figure EMEA Neuroprotection Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Neuroprotection Revenue (Million USD) by Players (2013-2018)
Table EMEA Neuroprotection Revenue Share by Players (2013-2018)
Table 2017 EMEA Neuroprotection Revenue Share by Players
Table 2017 EMEA Neuroprotection Revenue Share by Players
Table EMEA Neuroprotection Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Neuroprotection Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Neuroprotection Sales Share by Type (2013-2018)
Figure Sales Market Share of Neuroprotection by Type (2013-2018)
Figure EMEA Neuroprotection Sales Market Share by Type (2013-2018)
Table EMEA Neuroprotection Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Neuroprotection Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Neuroprotection by Type in 2017
Table EMEA Neuroprotection Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Neuroprotection Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Neuroprotection Sales Share by Application (2013-2018)
Figure Sales Market Share of Neuroprotection by Application (2013-2018)
Figure EMEA Neuroprotection Sales Market Share by Application in 2017
Table EMEA Neuroprotection Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Neuroprotection Sales Share by Region (2013-2018)
Figure Sales Market Share of Neuroprotection by Region (2013-2018)
Figure EMEA Neuroprotection Sales Market Share in 2017
Table EMEA Neuroprotection Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Neuroprotection Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Neuroprotection by Region (2013-2018)
Figure EMEA Neuroprotection Revenue Market Share Regions in 2017
Table EMEA Neuroprotection Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Neuroprotection Revenue and Growth Rate (2013-2018)
Table Europe Neuroprotection Sales (K Units) by Type (2013-2018)
Table Europe Neuroprotection Market Share by Type (2013-2018)
Figure Europe Neuroprotection Market Share by Type in 2017
Table Europe Neuroprotection Sales (K Units) by Application (2013-2018)
Table Europe Neuroprotection Market Share by Application (2013-2018)
Figure Europe Neuroprotection Market Share by Application in 2017
Table Europe Neuroprotection Sales (K Units) by Countries (2013-2018)
Table Europe Neuroprotection Sales Market Share by Countries (2013-2018)
Figure Europe Neuroprotection Sales Market Share by Countries (2013-2018)
Figure Europe Neuroprotection Sales Market Share by Countries in 2017
Table Europe Neuroprotection Revenue (Million USD) by Countries (2013-2018)
Table Europe Neuroprotection Revenue Market Share by Countries (2013-2018)
Figure Europe Neuroprotection Revenue Market Share by Countries (2013-2018)
Figure Europe Neuroprotection Revenue Market Share by Countries in 2017
Figure Germany Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure France Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure UK Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Neuroprotection Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Neuroprotection Sales (K Units) by Type (2013-2018)
Table Middle East Neuroprotection Market Share by Type (2013-2018)
Figure Middle East Neuroprotection Market Share by Type (2013-2018)
Table Middle East Neuroprotection Sales (K Units) by Applications (2013-2018)
Table Middle East Neuroprotection Market Share by Applications (2013-2018)
Figure Middle East Neuroprotection Sales Market Share by Application in 2017
Table Middle East Neuroprotection Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Neuroprotection Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Neuroprotection Sales Volume Market Share by Countries in 2017
Table Middle East Neuroprotection Revenue (Million USD) by Countries (2013-2018)
Table Middle East Neuroprotection Revenue Market Share by Countries (2013-2018)
Figure Middle East Neuroprotection Revenue Market Share by Countries (2013-2018)
Figure Middle East Neuroprotection Revenue Market Share by Countries in 2017
Figure Saudi Arabia Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Neuroprotection Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Neuroprotection Sales (K Units) by Type (2013-2018)
Table Africa Neuroprotection Sales Market Share by Type (2013-2018)
Figure Africa Neuroprotection Sales Market Share by Type (2013-2018)
Figure Africa Neuroprotection Sales Market Share by Type in 2017
Table Africa Neuroprotection Sales (K Units) by Application (2013-2018)
Table Africa Neuroprotection Sales Market Share by Application (2013-2018)
Figure Africa Neuroprotection Sales Market Share by Application (2013-2018)
Table Africa Neuroprotection Sales Volume (K Units) by Countries (2013-2018)
Table Africa Neuroprotection Sales Market Share by Countries (2013-2018)
Figure Africa Neuroprotection Sales Market Share by Countries (2013-2018)
Figure Africa Neuroprotection Sales Market Share by Countries in 2017
Table Africa Neuroprotection Revenue (Million USD) by Countries (2013-2018)
Table Africa Neuroprotection Revenue Market Share by Countries (2013-2018)
Figure Africa Neuroprotection Revenue Market Share by Countries (2013-2018)
Figure Africa Neuroprotection Revenue Market Share by Countries in 2017
Figure South Africa Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Table Daiichi Sankyo Company Neuroprotection Basic Information List
Table Daiichi Sankyo Company Neuroprotection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Daiichi Sankyo Company Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Daiichi Sankyo Company Neuroprotection Sales Market Share in EMEA (2013-2018)
Figure Daiichi Sankyo Company Neuroprotection Revenue Market Share in EMEA (2013-2018)
Table Eli Lilly and Company Neuroprotection Basic Information List
Table Eli Lilly and Company Neuroprotection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly and Company Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Eli Lilly and Company Neuroprotection Sales Market Share in EMEA (2013-2018)
Figure Eli Lilly and Company Neuroprotection Revenue Market Share in EMEA (2013-2018)
Table Allergan Neuroprotection Basic Information List
Table Allergan Neuroprotection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Allergan Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Allergan Neuroprotection Sales Market Share in EMEA (2013-2018)
Figure Allergan Neuroprotection Revenue Market Share in EMEA (2013-2018)
Table Dr. Reddy’s Laboratories Neuroprotection Basic Information List
Table Dr. Reddy’s Laboratories Neuroprotection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Dr. Reddy’s Laboratories Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Dr. Reddy’s Laboratories Neuroprotection Sales Market Share in EMEA (2013-2018)
Figure Dr. Reddy’s Laboratories Neuroprotection Revenue Market Share in EMEA (2013-2018)
Table Teva Pharmaceutical Neuroprotection Basic Information List
Table Teva Pharmaceutical Neuroprotection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Teva Pharmaceutical Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Teva Pharmaceutical Neuroprotection Sales Market Share in EMEA (2013-2018)
Figure Teva Pharmaceutical Neuroprotection Revenue Market Share in EMEA (2013-2018)
Table Novartis Neuroprotection Basic Information List
Table Novartis Neuroprotection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Novartis Neuroprotection Sales Market Share in EMEA (2013-2018)
Figure Novartis Neuroprotection Revenue Market Share in EMEA (2013-2018)
Table AstraZeneca Neuroprotection Basic Information List
Table AstraZeneca Neuroprotection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure AstraZeneca Neuroprotection Sales Market Share in EMEA (2013-2018)
Figure AstraZeneca Neuroprotection Revenue Market Share in EMEA (2013-2018)
Table Astrocyte Pharmaceuticals Neuroprotection Basic Information List
Table Astrocyte Pharmaceuticals Neuroprotection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Astrocyte Pharmaceuticals Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Astrocyte Pharmaceuticals Neuroprotection Sales Market Share in EMEA (2013-2018)
Figure Astrocyte Pharmaceuticals Neuroprotection Revenue Market Share in EMEA (2013-2018)
Table F. Hoffmann-La Roche Neuroprotection Basic Information List
Table F. Hoffmann-La Roche Neuroprotection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Neuroprotection Sales Market Share in EMEA (2013-2018)
Figure F. Hoffmann-La Roche Neuroprotection Revenue Market Share in EMEA (2013-2018)
Table Biogen Neuroprotection Basic Information List
Table Biogen Neuroprotection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Biogen Neuroprotection Sales (K Units) and Growth Rate (2013-2018)
Figure Biogen Neuroprotection Sales Market Share in EMEA (2013-2018)
Figure Biogen Neuroprotection Revenue Market Share in EMEA (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neuroprotection
Figure Manufacturing Process Analysis of Neuroprotection
Figure Neuroprotection Industrial Chain Analysis
Table Raw Materials Sources of Neuroprotection Major Manufacturers in 2017
Table Major Buyers of Neuroprotection
Table Distributors/Traders List
Figure EMEA Neuroprotection Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Neuroprotection Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Neuroprotection Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Neuroprotection Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Neuroprotection Sales Market Share Forecast by Region (2018-2025)
Table EMEA Neuroprotection Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Neuroprotection Revenue Market Share Forecast by Region (2018-2025)
Table Europe Neuroprotection Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Neuroprotection Sales Market Share Forecast by Countries (2018-2025)
Table Europe Neuroprotection Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Neuroprotection Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Neuroprotection Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Neuroprotection Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Neuroprotection Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Neuroprotection Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Neuroprotection Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Neuroprotection Sales Market Share Forecast by Countries (2018-2025)
Table Africa Neuroprotection Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Neuroprotection Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Neuroprotection Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Neuroprotection Sales Market Share Forecast by Type (2018-2025)
Table EMEA Neuroprotection Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Neuroprotection Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources